889 related articles for article (PubMed ID: 23581598)
1. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult Diabetes Control and Management.
Sazlina SG; Mastura I; Ahmad Z; Cheong AT; Adam BM; Jamaiyah H; Lee PY; Syed-Alwi SA; Chew BH; Sriwahyu T
Geriatr Gerontol Int; 2014 Jan; 14(1):130-7. PubMed ID: 23581598
[TBL] [Abstract][Full Text] [Related]
2. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
[TBL] [Abstract][Full Text] [Related]
5. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
Mattoo V; Eckland D; Widel M; Duran S; Fajardo C; Strand J; Knight D; Grossman L; Oakley D; Tan M;
Clin Ther; 2005 May; 27(5):554-67. PubMed ID: 15978304
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk profiles in relation to newly diagnosed type 2 diabetes diagnosed by either glucose or HbA1c criteria in Chinese adults in Qingdao, China.
Qie LY; Sun JP; Ning F; Pang ZC; Gao WG; Ren J; Nan HR; Zhang L; Qiao Q;
Diabet Med; 2014 Aug; 31(8):920-6. PubMed ID: 24824545
[TBL] [Abstract][Full Text] [Related]
10. Age ≥ 60 years was an independent risk factor for diabetes-related complications despite good control of cardiovascular risk factors in patients with type 2 diabetes mellitus.
Chew BH; Ghazali SS; Ismail M; Haniff J; Bujang MA
Exp Gerontol; 2013 May; 48(5):485-91. PubMed ID: 23454736
[TBL] [Abstract][Full Text] [Related]
11. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
12. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
13. Predictive and explanatory factors of cardiovascular disease in people with adequately controlled type 2 diabetes.
Hashemi Madani N; Ismail-Beigi F; Khamseh ME; Malek M; Ebrahimi Valojerdi A
Eur J Prev Cardiol; 2017 Jul; 24(11):1181-1189. PubMed ID: 28447480
[TBL] [Abstract][Full Text] [Related]
14. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
[TBL] [Abstract][Full Text] [Related]
15. Association of physical activity with glycaemic control and cardiovascular risk profile in 65 666 people with type 2 diabetes from Germany and Austria.
Hermann G; Herbst A; Schütt M; Kempe HP; Krakow D; Müller-Korbsch M; Holl RW;
Diabet Med; 2014 Aug; 31(8):905-12. PubMed ID: 24646320
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes.
Shand B; Scott R; Connolly S; Clarke R; Baker J; Elder P; Frampton C; Yeo J
Diabetes Obes Metab; 2007 Jul; 9(4):540-7. PubMed ID: 17587396
[TBL] [Abstract][Full Text] [Related]
17. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
[TBL] [Abstract][Full Text] [Related]
18. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.
Xu L; Chan WM; Hui YF; Lam TH
Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus.
Göbl CS; Brannath W; Bozkurt L; Handisurya A; Anderwald C; Luger A; Krebs M; Kautzky-Willer A; Bischof MG
Gend Med; 2010 Dec; 7(6):593-9. PubMed ID: 21195359
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
Ahmad Khan H
Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
